Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Allergan
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Successful completion of either Study RLM-MD-03 or Study RLM-MD-04
Ability to provide written informed consent (IC) prior to any study procedures and willingness and ability to comply with study procedures
Demonstration of adequate compliance with the study procedures in Study RLM-MD-03 or RLM-MD-04, in the opinion of the investigator.
You may not be if
Participant is planning to receive an investigational drug (other than study intervention) or investigational device at any time during Study 3071-305-020
Participant has an unresolved adverse event (AE) from a lead-in study, ie, a clinically significant finding on physical examination, clinical laboratory test, or 12-lead electrocardiogram (ECG) that, in the investigator's opinion, would limit the participant's ability to participate in or complete the study
Any other reason that, in the investigator's opinion, would confound proper interpretation of the study or expose a participant to unacceptable risk, including renal, hepatic, or cardiopulmonary disease
Females who are pregnant, nursing, or planning a pregnancy during the study.
